Indeed, there were more TGFBR2+ NK cells (CD16+ CD56+ TGFBR2+) in SCLC than NSCLC (Figure 6h and Figure S8h, Supporting Information). This evidence concerns the gene TGFBR2 and non-small cell lung carcinoma.